The only available automated test to determine the procoagulant activity of phospholipids
This innovating test is an indirect marker of Tissue Factor exposure In Vivo.
Your connexion to coagulation expertise.
STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control*
Rivaroxaban is a new oral anticoagulant developed by Bayer HealthCare and sold under the trade name Xarelto®. It is a direct factor Xa inhib...
How can haemophilia A and type 2N von Willebrand disease be distinguished? To answer this question, Stago has developed a new diagnostic too...
Am 01.01.2012 starten wir mit über 20 Spezialisten aus Service, Applikation und Verkauf in ganz Deutschland. Dieses Team konzentriert sich zusammen mit den Mitarbeitern in unserer Niederlassung in Düsseldorf, aber auch mit unseren Kollegen weltweit, auf die Einhaltung unserer Grundwerte.
Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.
01 - 04 Februar 2012
31 August - 01 Septembre 2012
Did you know?
In 1976, Stenflo purified and partially characterised protein C. During his isolation procedure, Stenflo obtained four peaks in his chromatography elution steps. These peaks where labelled sequentially A through D; the third peak contained a «new» protein has been called arbitrarily protein C.
Recent Jobs
We don't have any job openings at the moment. Please check back later. If you would still like to apply, you are welcome to send us an unsolicited application.
Apply
